|
|
Article: Cancer Vaccines: Asymptotically Approaching Product Approval
- Article from:
- Biopharm International
- Article date:
- August 1, 2007
- Author:
CopyrightCopyright Advanstar Communications, Inc. Aug 2007. Provided by ProQuest LLC. (Hide copyright information)
|
Cancer vaccines under development have proven safe and well-tolerated, but establishing efficacy remains a challenge.
ABSTRACT
The notion that the immune system can prevent the emergence and growth of cancer is a century old. Despite considerable evidence in animal models that "cancer vaccines" induce effective immunological responses against tumors, the development of efficacious vaccines to treat cancer in humans has been much slower and far less promising. In the past decade, however, several vaccine strategies have made considerable clinical advancement, renewing the interest and confidence that a human cancer vaccine will be successfully launched. This article highlights several ...
Related newspaper, magazine, and journal articles:
|
|
Article: Studies conducted at T.J. Harris et al on cancer ...
Cancer Weekly;
October 14, 2008 ;
700+ words
... ... patient's anti-tumor immune response. As immunotherapy ... of priming an anti-tumor immune response in animals ... immunotherapy. Anti-tumor immune responses occurred ... colleagues (see also Cancer Vaccines). The researchers ...
|
|